Hot Features
Registrieren Sie sich kostenlos, um Echtzeitkurse, interaktive Charts, Live-Optionsfluss und mehr zu erhalten.
Vigil Neuroscience Inc is a microglia-focused therapeutics company treating both rare and common neurodegenerative diseases by restoring the vigilance of microglia, the sentinel cells of the brain's immune system. It is utilizing the tools of modern neuroscience drug development across multiple ther... Vigil Neuroscience Inc is a microglia-focused therapeutics company treating both rare and common neurodegenerative diseases by restoring the vigilance of microglia, the sentinel cells of the brain's immune system. It is utilizing the tools of modern neuroscience drug development across multiple therapeutic modalities to rapidly deliver precision-based therapies to improve the lives of patients and families. Mehr anzeigen
WATERTOWN, Mass., Nov. 12, 2024 (GLOBE NEWSWIRE) -- Vigil Neuroscience, Inc. (Nasdaq: VIGL), a clinical-stage biotechnology company committed to harnessing the power of microglia for the...
- Final analysis from IGNITE Phase 2 clinical trial evaluating iluzanebart in ALSP planned for first half of 2025 - - Data from Phase 1 clinical trial evaluating VG-3927 in Alzheimer’s Disease on...
WATERTOWN, Mass., Nov. 05, 2024 (GLOBE NEWSWIRE) -- Vigil Neuroscience, Inc. (Nasdaq: VIGL), a clinical-stage biotechnology company committed to harnessing the power of microglia for the...
| Zeitraum † | Änderung | Änderung % | Handelsbeginn | Hoch | Niedrig | Durchsch. Volumen | VWAP | |
|---|---|---|---|---|---|---|---|---|
| 1 | -0.061 | -3.46394094265 | 1.761 | 1.89 | 1.54 | 462160 | 1.64667298 | CS |
| 4 | -0.64 | -27.3504273504 | 2.34 | 2.54 | 1.54 | 341216 | 1.9612184 | CS |
| 12 | -1.73 | -50.4373177843 | 3.43 | 4.12 | 1.54 | 200765 | 2.44689421 | CS |
| 26 | -2.8 | -62.2222222222 | 4.5 | 4.97 | 1.54 | 342302 | 3.74132649 | CS |
| 52 | -1.95 | -53.4246575342 | 3.65 | 6.06 | 1.54 | 240943 | 3.69446572 | CS |
| 156 | -10.3 | -85.8333333333 | 12 | 18.27 | 1.54 | 123799 | 5.3242092 | CS |
| 260 | -10.3 | -85.8333333333 | 12 | 18.27 | 1.54 | 123799 | 5.3242092 | CS |
Support: +44 (0) 203 8794 460 | support@advfn.de
Durch das Benutzen des ADVFN Angebotes akzeptieren Sie folgende Allgemeine Geschäftsbedingungen
Premium
